Earnings NewsHealthcareBiodel reports FQ3 resultsAug. 14, 2015 8:51 AM ETAlbireo Pharma, Inc. (ALBO) StockBy: SA News Team2 Comments Biodel (BIOD) FQ3 results: Revenues: $0; R&D Expense: $5.1M (+41.7%); SG&A: $1.5M (+15.4%); Net Loss: ($6.5M) (-103.1%); Loss Per Share: ($0.12) (+20.0%); Quick Assets: $44.4M (+80.5%). No guidance given. Recommended For YouRelated StocksSymbolLast Price% ChgALBO--Albireo Pharma, Inc.Trending AnalysisTrending News